Immunotherapy benefits relapsed stem cell transplant recipients – Science Daily
|
Immunotherapy benefits relapsed stem cell transplant recipients
Science Daily "We believe the donor immune cells are present but can't recognize the tumor cells because of inhibitory signals that disguise them," said Matthew Davids, MD MMSc, a member of the Division of Hematologic Malignancies at Dana-Farber and first author of … |
